News & Updates

Show Multimedia Only

Original New Drug Application Approvals by US FDA (16-31 July 2024)

06 Aug 2024

New drug applications approved by US FDA as of 16-31 July 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

06 Aug 2024

How viable is a self-administered injection in adults with HIV?

05 Aug 2024 by

A substudy of the phase III FLAIR study has found comparable efficacy and pharmacokinetics for cabotegravir (CAB) plus rilpivirine (RPV) via subcutaneous (SC) administration relative to those via intramuscular (IM) gluteal injections among virally suppressed individuals living with HIV-1.

05 Aug 2024

Extended TB surveillance needed for specific IGRA-negative individuals

30 Jul 2024 by

Certain individuals initially testing negative for tuberculosis (TB) by interferon-gamma release assay (IGRA) may later contract the infection and therefore require extended follow-up due to increased risk, as reported in a study from Singapore.

30 Jul 2024

Systemic fluoroquinolone treatment not a risk factor for uveitis, retinal detachment

28 Jul 2024

Individuals who received systemic fluoroquinolone do not appear to have an increased risk of uveitis or retinal detachment, as shown in a study.

28 Jul 2024

Can mouthwash cut COVID-19 salivary viral load?

23 Jul 2024 by

In COVID-19 patients who had mild or no symptoms, the use of 0.05% cetylpyridinium chloride (CPC) and 0.01% on-demand aqueous chlorine dioxide (ACD) mouthwashes did not lead to a reduction in SARS-CoV-2 salivary viral load.

23 Jul 2024

Antibiotic overtreatment prevalent in children with PPE/PE

22 Jul 2024 by

Children with parapneumonic effusion (PPE) or pleural empyema (PE) are often overly treated with antibiotics, particularly the frequent use of antibiotic combination therapy, reports a Germany study.

22 Jul 2024

Postexertional malaise, fatigue common PASC symptoms in pregnant women

21 Jul 2024

Nearly 10 percent of pregnant women experience postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), with the most common symptoms including postexertional malaise, fatigue, and gastrointestinal symptoms, according to a study.

21 Jul 2024

Acute benign myositis may occur in kids with flu infection

21 Jul 2024 by

Children with influenza A virus infection are susceptible to acute benign myositis (ABM), with most patients showing clinical characteristics consistent with postfebrile myalgia, reports a study.